Active ingredientOpipramolCat. No. P-O025-001CAS 315-72-0Family · Pharmaceutical analytical standards
Opipramol
An anxiolytic with a tricyclic structure, related to imipramine, introduced in 1961 and indicated for generalised anxiety disorder and somatoform disorders. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Although it resembles tricyclic antidepressants it does not block serotonin and noradrenaline reuptake: it acts mainly on sigma-1 receptors, while blocking histamine H1 receptors accounts for its calming effect.
Go to the active ingredient →Active ingredientOpipramolCat. No. P-O025-001CAS 315-72-0
Active ingredientOpipramol DihydrochlorideCat. No. P-O025-002CAS 909-39-7
Isotopically labelledOpipramol-d4Cat. No. P-O025-003CAS 1215716-70-3![5-(3-Chloropropyl)-5H-dibenz[b,f]azepine](https://img.vitasanlabs.com/vsl-struct/P-O025-004.svg?v=41e934f030)
Impurity5-(3-Chloropropyl)-5H-dibenz[b,f]azepineCat. No. P-O025-004CAS 51551-40-7
ImpurityOpipramol Impurity 1 DihydrochlorideCat. No. P-O025-005CAS 2727065-82-7
ImpurityAcridine-9-carbaldehydeCat. No. P-O025-006CAS 885-23-4
ImpurityDeshydroxyethyl opipramolCat. No. P-O025-007CAS 4346-38-7
ImpurityOpipramol Di-N-OxideCat. No. P-O025-008CAS 2724726-55-8
ImpurityOpipramol N-OxideCat. No. P-O025-009CAS 2732277-08-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.